SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC gets final nod for Cefixime 400 mg Tablets

18 Dec 2024 Evaluate

FDC has received final approval from U.S. Food and Drug Administration (USFDA) for the Company’s Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets.

In November 2024, FDC recalled 1,55,232 bottles of Timolol Maleate ophthalmic solution in the US market. The company recalled the affected lot due to ‘Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.’

FDC is among India’s leading fully integrated pharmaceutical companies.

FDC Share Price

366.45 -5.85 (-1.57%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×